Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02592590 · ClinicalTrials.gov registry record · NA

Multiphase Activity Promotion Study

A NA study, sponsored by University of Illinois at Urbana-Champaign.

Completed
Registry status
NA
Development phase
118
Enrollment target

NCT02592590: Completed NA study, sponsored by University of Illinois at Urbana-Champaign.

NCT02592590 is a NA study that has completed, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 118 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02592590, a NA study, has completed, sponsored by University of Illinois at Urbana-Champaign.

COMPLETED
Registry status
NA
Development phase
118 participants
Enrollment target

Study Summary

The purpose of this study is to determine the individual and combined effectiveness of two smartphone-based tools for improving physical activity. The first is an individualized and guided goal-setting module, and the second uses "points", "levels", and "badges" to provide instant positive feedback throughout the program. It is hypothesized that both components will be effective, and greater effects will be noted for those receiving both components.

Primary Outcome

In the week prior to the start of the program and in the twelfth week of the program, participants will wear an actigraph brand accelerometer on their hip during waking hours for seven consecutive days.

Interventions

  • BEHAVIORAL Group A
  • BEHAVIORAL Group B
  • BEHAVIORAL Group C
  • BEHAVIORAL Group D

Trial Details

FieldValue
Enrollment Target 118 participants
Start Date 2015-11
Est. Completion 2016-07
Phase NA

What the finished NCT02592590 record still lists

NCT02592590 is an interventional study that assigns participants to a tested intervention. The registered 118 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 4 interventions - of which Group A is the first listed.

NCT02592590 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02592590 about?

NCT02592590 is a clinical study titled "Multiphase Activity Promotion Study". The purpose of this study is to determine the individual and combined effectiveness of two smartphone-based tools for improving physical activity. The first is an individualized and guided goal-setting module, and the second uses "points", "levels", and "badges" to provide instant positive feedback ...

What is the current status of trial NCT02592590?

This trial is currently completed. It is a NA study. The enrollment target is 118 participants. The study started on 2015-11. Estimated completion is 2016-07.

What interventions are being tested in trial NCT02592590?

The interventions under investigation include: Group A (BEHAVIORAL), Group B (BEHAVIORAL), Group C (BEHAVIORAL), Group D (BEHAVIORAL).

Who is sponsoring clinical trial NCT02592590?

This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02592590's enrollment target sits among peer trials

118 803rd of 2000 higher than 1,194 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03821623 · 118 participants · Phase 2

    Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults

  • NCT04040959 · 118 participants · Phase 2

    Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD

  • NCT04696029 · 118 participants · Phase 2

    DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma

  • NCT05223192 · 118 participants · NA

    The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02592590, the US trial registry maintained by the National Library of Medicine. NCT02592590 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.